ATUGEN
ATUGEN
Industry:
Biotechnology Health Care Medical
Founded:
1999-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Status:
Active
Similar Organizations
Activen
Activen is a biotechnology company specialised in drug discovery.
Advanced Genomic Technology
AGT is a biotechnology company based in Louisville, Kentucky.
Aneumed
Aneumed is a biotechnology company based in California, United States.
Boditech Med
Boditech Med is a biotechnology company based in Chuncheon.
Cellectis
Cellartis AB is a biotechnology company based in Sweden.
fasteris
Fasteris is a Swiss biotechnology company based in Geneva.
Myovec
Myovec is a company specialized in gene therapy.
Syndivia
Syndivia is a biotechnology company based in France.
More informations about "Atugen"
Atugen - The Human Genome Project: An Annotated & Interactive …
Atugen was created as a spin-off from Ribozyme Pharmaceuticals (later Sirna Therapeutics) to focus on target discovery and validation collaborations with pharmaceutical companies using …See details»
Atugen Biotechnology GmbH - Life-Sciences-Europe.com
BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry Association (BIA) …See details»
atugen AG - life-sciences-europe.com
Jun 16, 1998 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Atugen AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Atugen AG with its drug pipeline, therapeutic area, technology platform, 15 literature, Technology Platform:Small interfering RNA, Drug:Atu-014.See details»
BioPharmaLink profile of Atugen AG, Germany,
Atugen has assembled a broad-based technology platform to bridge the gap between sequence information and gene function/target validation. These tools can be used to evaluate gene …See details»
Peter Buckel Appointed CEO of atugen AG - bionity.com
Jun 9, 2004 Peter Buckel brings to atugen his extensive experience in both the pharmaceutical industry and the biotechnology sector. His previous position was as co-founder and CEO of …See details»
Atugen - Overview, News & Similar companies | ZoomInfo.com
Who is Atugen. Atugen is a leader in RNAi therapeutics. This Company has developed novel, chemically modified proprietary siRNA molecules ("AtuRNAi") and a propri etary delivery …See details»
Atugen - Crunchbase
A biotechnology company based in Berlin, Germany.See details»
atugen AG raises EUR 5 million venture funding for siRNA …
Mar 16, 2004 Earlier this year atugen launched a new program to develop siRNA therapeutics. This program is designed to leverage attugen's accumulated know-how and proprietary …See details»
ATUGEN AG innovation strategy - GoodIP
ATUGEN AG has a total of 38 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and …See details»
Atu-014 - Drug Targets, Indications, Patents - Synapse - Patsnap
Atu-014: a RNA interference Drug, Initially developed by Atugen AG, Now, its global highest R&D status is Preclinical, Mechanism: RNA interference, Active Org.: Atugen AG. ... Active …See details»
SR Pharma Buying Atugen For £6.2M, Raising Money - bioworld.com
Jul 13, 2005 The venture capital backers of Atugen have put €31 million (US$37.2 million) into Atugen since its formation in 1998. In addition, the 34-employee company has raised €6 billion …See details»
Atugen AG - VentureRadar
Similar Companies: Hemagen Diagnostics USA n/a n/a. Avidas Pharmaceuticals USA n/a n/a. Ardena Belgium n/a Ardena is a fully integrated Contract Development & Manufacturing …See details»
atugen and Aventis to collaborate in identifying siRNA …
Berlin. atugen AG announced that it has signed a collaboration agreement with Aventis to identify siRNA compounds with the potential for therapeutic development. It is planned to combine …See details»
First US–German start-up | Nature Biotechnology
16, 812, 1998), Atugen is one of the first biotechnology firms with US parents to receive funding from the German government, which provided it with a cash handout of about $7 million. …See details»
SR Pharma acquires Atugen - 2005-06-21 - Crunchbase
Jun 21, 2005 SR Pharma acquires Atugen on 2005-06-21 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. ... Edit Overview Section. Acquired …See details»
drug target identification technology feature A question of biology
The siRNA drug-development company Atugen in Berlin, Germany, also develops siRNAs as both reagents for target identification and validation and as potential therapeutics. Atugen’s …See details»
Atu 027 - AdisInsight - Springer
Nov 4, 2017 Silence Therapeutics (formerly Atugen AG) was developing Atu 027, a small interfering RNA (siRNA) therapeutic, for the treatment of cancer. Atu 027 targeted the ... If …See details»
Research programme: antisense oligonucleotides - Atugen/Novo …
Atugen (now Silence Therapeutics) and Novo Nordisk were collaborating in the development of a programme for target validation in diabetes and other relatedSee details»